Ranbaxy Laboratories: The Winning Chemistry



IBS CDC IBS CDC IBS CDC IBS CDC RSS Feed

Code : COM0043

Year : 2004

Industry : Health Care

Region : UK

Teaching Note:Not Available

Structured Assignment :Not Available

Buy This Case Study
OR
       

Abstract: In February 2004, Indian pharmaceutical major Ranbaxy Laboratories had achieved the unique distinction of crossing the billion-dollar mark in annual sales.

The company was now in the implementation phase of its 'vision garuda' that aimed to make the company achieve US $5 billion in annual sales by 2012.

Ranbaxy's strategy was to be prepared for the International Patent Law (IPL) regime to be implemented from January 2005, by a combination of increased spending in basic research, generic drugs and global expansion.

Pedagogical Objectives:

  • To discuss the competitive scenario of the Indian pharmaceutical industry
  • To discuss how Ranbaxy is positioning itself for the future.

    • For Case Books Click Here >>

    For Case eBooks Click Here >>

    Keywords : Ranbaxy Laboratories Limited; Growth strategy; The Indian pharmaceutical industry; International Patent Law; General Agreement on Trade and Tariffs (GATT); Growth Strategies Case Study; Dr. Parvinder Singh; Trade related aspects of intellectual property rights (TRIPS); Generic drugs; Product patents, process patents; Mergers and acquisitions; Research and development; Blockbuster drugs; Reverse engineering; Global expansion strategy

    Contents :
    » The Indian Pharmaceutical Industry
    » Genesis and Growth of Ranbaxy
    » Ranbaxy's Prescription for Growth


    Case Introduction >>


    Contact us: IBS Case Development Centre (IBSCDC), IFHE Campus, Donthanapally, Sankarapally Road, Hyderabad-501203, Telangana, INDIA.
    Mob: +91- 9640901313,
    E-mail: casehelpdesk@ibsindia.org

    ©2020-2025 IBS Case Development Centre. All rights reserved. | Careers | Privacy Policy | Terms of Use | Disclosure | Site Map xml sitemap